Epistaxis

Disclaimer

These guidelines have been produced to guide clinical decision making for the medical, nursing and allied health staff of Perth Children’s Hospital. They are not strict protocols, and they do not replace the judgement of a senior clinician. Clinical common-sense should be applied at all times. These clinical guidelines should never be relied on as a substitute for proper assessment with respect to the particular circumstances of each case and the needs of each patient. Clinicians should also consider the local skill level available and their local area policies before following any guideline.

Read the full CAHS clinical disclaimer

Aim

To guide Emergency Department (ED) staff with the assessment and management of epistaxis.

Background¹

Epistaxis in children is usually a minor self-limiting condition which responds to simple first aid measures
Rarely, a child with an underlying coagulation disorder may present with serious or even life threatening epistaxis
Children who present with a significant epistaxis that requires nasal packing should be discussed with an ear, nose and throat (ENT) specialist.

Anatomy²

The nasal cavity has a rich vascular supply from several terminal branches of the internal and external carotid arteries
The mucosal surfaces of the anterior septum (Little’s area or Kiesselbach’s plexus) has a high concentration of vascular anastomoses
95% of epistaxis in children occurs from Little’s area.

Aetiology²

Often, no cause is apparent.

The most common causes of epistaxis in children include:

Local

Trauma – e.g. nose picking, nasal fracture, forceful nose blowing, foreign body
Inflammation (e.g. upper respiratory tract infection, allergic rhinitis)
Dry nasal mucosa (hot, dry climates)
Hereditary Haemorrhagic Telangiectasia (HHT) is a rare autosomal dominant condition which often presents with epistaxis prior to 12 years of age.²

Systemic

Coagulation disorder (e.g. haemophilia, von Willebrand disease, thrombocytopenia).

Assessment

Investigations

Most cases need no investigation
Patients in whom epistaxis is recurrent, difficult to control or who have other features of coagulopathy (e.g. easy bruising) may warrant investigation for an underlying coagulation disorder.
- Full blood count (FBC) and Coagulation profile should be done to identify or exclude conditions such as haemophilia, von Willebrand’s disease or thrombocytopaenia.
Epistaxis is rare before 2 years of age. Cases in younger children should raise suspicion of underlying coagulopathy or Non-Accidental Injury as an inciting factor.³
The other demographic of interest are teenage males, where recurrent or profuse epistaxis (particularly posterior epistaxis) can be associated with Juvenile Nasal Angiofibroma (JNA). JNA is a benign fibrovascular neoplasm that typically arises in the region of the sphenopalatine foramen in the lateral wall of the nose.³

Management¹

Resuscitation

Rarely a child will present with life threatening haemorrhage. If haemodynamically unstable or shocked general principles of resuscitation apply (refer to Serious illness).

Position the patient upright if possible (i.e. not shocked) and apply pressure to nasal ala
If unconscious, lie on their side
Instruct the patient to breathe through the mouth, and clear the upper airway by suctioning blood from the oropharynx using a Yankauer sucker.
Prompt venous access and volume resuscitation with crystalloid or blood
Prompt nasal packing with a haemostatic dressing or device
Urgent ENT consultation
After adequate resuscitation, formal haemostatic control in the operating theatre may be necessary if bleeding persists.

First aid

Sit up and lean forward (do not tilt the head back – results in concealed, swallowed blood)
Pinch nasal ala (soft anterior part of the nose) to exert pressure on the Little's area.
- Pressure should be applied for a full 10 minutes, by the clock
- Do not stop pressure intermittently to check for bleeding
Application of a vasoconstrictor lidocaine (lignocaine) with phenylephrine nasal spray (Co-Phenylcaine™ Forte) or dilute adrenaline (epinephrine) may be used as an adjunct to pressure. If using lidocaine (lignocaine) with phenylephrine nasal spray , be aware of the cumulative dose of lidocaine (lignocaine) as the potential for toxicity exists, especially via traumatised mucosal surfaces
This technique will control the majority of epistaxis in the ED
If simple nose pressure of reasonable duration does not achieve haemostasis, then anterior nasal packing or cautery may be needed.

Anterior nasal packing

The most basic emergency procedure that can be performed with good control of epistaxis is anterior nasal packing. This is generally poorly tolerated in children and most children will require both topical anaesthetic spray and carefully titrated intravenous opiate such as morphine to allow packing. Refer to Morphine Monograph – Medication Management Manual (Internal WA Health only).

Technique

Material: packing forceps, nasal packing material (e.g. Nasopore® or Merocel®) or balloon tamponade device (e.g. Rapid-Rhino), topical vasoconstrictor / anaesthetic spray (e.g. lidocaine (lignocaine) with phenylephrine nasal spray (Co-Phenylcaine™ Forte)).
Position patient sitting upright
Spray a topical vasoconstrictor / anaesthetic into each nostril
Titrate IV Morphine to provide anxiolysis and decrease the distress of the packing procedure. Refer to Morphine Monograph – Medication Management Manual (Internal WA Health only).

Balloon Devices

A range of commercial devices exist to control either posterior bleeds, anterior bleeds or both.
Alternatively, a size 8 French Foley catheter, inserted deep into the nasopharynx, inflated with air and then pulled anteriorly to sit in the posterior choana can control posterior bleeds.
Rapid Rhino (epistaxis device) if available is preferable. They are available in different lengths between 5.5cm and 9cm and are covered in a fabric mesh that exudes a pro-coagulant, lubricating gel when soaked in water (not saline) before use.
Additional methods may be employed if anterior bleeds are coexistent.

Nasal Packing

With patient sitting up:

Choose appropriate size, larger tampons may be trimmed to size.
Coat the leading end of tampon with a lubricating ointment
Grasp with forceps and insert along nasal floor.
Tape strings to cheeks
A small amount of saline may be applied to tampon, to soften and expand it
Discuss patient disposition with ENT.

Nasal cauterisation- only by experienced doctors

Haemostasis and patient co-operation is required before cauterisation.
Silver Nitrate sticks are used for chemical cautery.
Mostly used to control bleeding vessels on the anterior part of the nasal septum (Little’s area).
Additional equipment: torch or head light, nasal speculum, suction.
Apply lidocaine (lignocaine) with phenylephrine nasal spray (Co-Phenylcaine™ Forte) to the area to vasoconstrict as well as anaesthetise the area. This can be sprayed on the area, but a better anaesthetic effect is produced if a similar volume of lidocaine (lignocaine) with phenylephrine nasal spray (Co-Phenylcaine™ Forte) is applied to the area for a longer period of time (20 minutes) via a small cotton-wool pledget.
Apply the silver nitrate stick to the edge of the bleeding area. Aim to cauterise the feeding vessels first before moving to the central bleeding focus.
Apply the stick for a maximum 10 seconds at a time. Generally, application for 3 seconds in one area is sufficient. If you want to move the silver nitrate applicator to an adjacent area, aim to roll the applicator rather than dragging it.
Cauterise a minimal part of the septum, to avoid ulceration.
Never cauterise both sides of the septum at the same time.

Discharge advice

Avoid nose picking or rubbing
First aid advice (as above) for future episodes
Apply an emollient ointment regularly (BD) to the area for at least one week. Continued emollient use may be beneficial, with emollients alone controlling 65-77%³ of recurrent paediatric epistaxis.
Referral to ENT clinic if epistaxis is a recurrent problem.

References

Textbook of Paediatric Emergency Medicine 3rd Edition Cameron P, Browne GJ, Mitra B, et al (2018) Publisher: Elsevier Edition updated
Messner AH (2014) Management of Epistaxis in Children. UpToDate. Accessed at www.uptodate.com
Patel N, Maddalozzo J, Billings KR. An update on management of pediatric epistaxis. Int J Pediatr Otorhinolaryngol. 2014 Aug;78(8):1400-4. doi: 10.1016/j.ijporl.2014.06.009. Epub 2014 Jun 16. PMID: 24972938.

Endorsed by:	Nurse, Co-director, Surgical Services	Date:	Jun 2022
		Review date:	Apr 2024

This document can be made available in alternative formats on request for a person with a disability.